A note: Recently the blog has been having issues with some readers being redirected to a sketchy Chinese pharmaceuticals site. I believe the issue has been resolved, but please reach out to me if you encounter anything weird. Much appreciated! … Continue reading →

The SEC has proposed rules changes that would effectively shut down all trading in non-reporting OTC-traded companies. I am strongly opposed to these rule changes. As proposed, the new rules would eliminate the ability of holders of non-reporting OTC company … Continue reading →